Feature

Solving the Problem of Insolubility: Part III

Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients

  • By

  • March 3, 2026

  • 6 min

Share

  • 1

    KinetiSol improves drug delivery by dissolving poorly soluble molecules.

  • 2

    Technology inspired by plastics recycling.

  • 3

    Recent studies show potential for parenteral and inhalation delivery.

  • 4

    KinetiSol won the Advancing Pharmacy Research Award.

  • 5

    Innovation is focusing on overcoming traditional drug development challenges.

  • 6

    Machine learning democratizes drug discovery, allowing smaller entities to contribute.

  • 7

    CDMOs are crucial for translating innovations into patient treatments.

Original Source(s)

Solving the Problem of Insolubility: Part III

Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients

  • March 3, 2026

  • 6 min

Related Content

Fox Chase Cancer Center Celebrates Innovation, Sustained Growth, and Upward Momentum

When it comes to cancer, our work can seem insurmountable. But look closer, and it offers enduring hope. Despite the demands — or perhaps because of them — the faculty and staff at Fox Chase Cancer Center steadily rise above to achieve more.

  • by

  • March 3, 2026

  • 1 min
Major Announcements for Axplora

CDMO announces multi-million-euro investment to expand lyophilization and appoints Head of Site

  • March 2, 2026

  • 2 min
Sequencing Therapies in Non-Hodgkin Lymphomas